Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric oxygen therapy as adjuvant to biologic therapy in moderate to severe ulcerative colitis
2023-507450-32-00Phase 3Completed
- Sponsor
- Medical University of Gdańsk
- Start
- May 2024
- Countries
- 1
01
Overview
Phase 3 trial of hyperbaric oxygen therapy in autoimmune colitis (2 arms), sponsored by Medical University of Gdańsk. Started May 2024; status: completed.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2023-507450-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507450-32-00.